MSI-H

Clinical trials for MSI-H explained in plain language.

Never miss a new study

Get alerted when new MSI-H trials appear

Sign up with your email to follow new studies for MSI-H, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1

New drug duo shows promise against aggressive colon cancer

Disease control Ongoing

This study tests whether giving two immunotherapy drugs (IBI310 and sintilimab) before surgery can eliminate or shrink tumors in people with a specific genetic type of colon cancer (MSI-H/dMMR). About 453 adults with stage IIB or III colon cancer that can be surgically removed wi…

Matched conditions: MSI-H

Phase: PHASE3 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control

Last updated Jun 27, 2026 12:39 UTC

MSI-H

Get alerted when new MSI-H trials appear

New drug duo shows promise against aggressive colon cancer